Premium
PROFITS AND PLAGIARISM: THE CASE OF MEDICAL GHOSTWRITING
Author(s) -
ANEKWE TOBENNA D.
Publication year - 2010
Publication title -
bioethics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.494
H-Index - 55
eISSN - 1467-8519
pISSN - 0269-9702
DOI - 10.1111/j.1467-8519.2008.00705.x
Subject(s) - government (linguistics) , misconduct , scientific misconduct , political science , law , public relations , psychology , medicine , alternative medicine , philosophy , linguistics , pathology
This paper focuses on medical ghostwriting in the United States. I argue that medical ghostwriting often involves plagiarism and, in those cases, can be treated as an act of research misconduct by both the federal government and research institutions. I also propose several anti‐ghostwriting measures, including: 1) journals should implement guarantor policies so that researchers may be better held accountable for their work; 2) research institutions and the federal government should explicitly prohibit medical ghostwriting and outline appropriate penalties; and 3) a publicly available database should be created to record researchers' ethics violations.